Chemistry:Halometasone

From HandWiki
Revision as of 00:04, 6 February 2024 by MainAI6 (talk | contribs) (fix)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
Halometasone
Halometasone.png
Halometasone cream.jpg
Clinical data
Trade namesSicorten
Other names(6S,8S,9R,10S,11S,13S,16R,17R)-2-chloro-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxy-acetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Topical
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC22H27ClF2O5
Molar mass444.90 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Halometasone is a potent (Group III) synthetic tri-halogenated corticosteroid for topical application possessing pronounced anti-inflammatory, antiexudative, antiepidermoplastic, antiallergic, and antipruritic properties. It has been approved in many European countries including Spain, Germany, Switzerland, Austria, Netherlands, Belgium, and Portugal and other regions such as China, Hong Kong, Turkey, Israel, South Africa and India.

It has been used to treat chronic psoriasis vulgaris[1] and non-infected acute eczematous dermatoses (eczema).[2] One study demonstrated that 0.05% halometasone cream was more effective than 0.05% betamethasone cream in treating dermatitis, though both were well tolerated, with no systemic adverse effects reported.[3]

References

  1. "Halometasone cream by day and halometasone ointment at night for the treatment of patients with chronic psoriasis vulgaris". The Journal of International Medical Research 11 (Suppl 1): 31–3. 1983. PMID 6339290. 
  2. "An overview of international clinical trials with halometasone cream". The Journal of International Medical Research 11 (Suppl 1): 1–7. 1983. PMID 6339286. 
  3. "[Comparative clinical trial of a new trihalogenated dermatocorticoid (halometasone) versus betamethasone dipropionate]". Zeitschrift für Hautkrankheiten 58 (4): 230–7. February 1983. PMID 6342285.